Introduction Prior reviews synthesized findings of studies on long-term cardiac complications
of COVID-19. However, the reporting and methodological quality of these studies has not …

Since the emergence of the SARS-CoV-2 virus in 2019, nearly 700 million COVID-19 cases
and 7 million deaths have been reported globally. Despite most individuals recovering …

Background Most of the previous studies on health sequelae of COVID-19 are uncontrolled
cohorts and include a relatively short follow-up. This population-based multi-center cohort …

Objectives To our knowledge, there is no systematic review examining CVD risks after a
SARS-CoV-2 infection over time, while also taking into account disease severity. All …

Results We included 63 controlled cohort studies, encompassing more than 96 million
participants. Based on five studies, we found a reduction in overall quality of life between …

Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

Cardiovascular diseases (CVD) are common in long COVID, yet the associated risk remains
uncertain. We aimed to quantify the risk of new‐onset cardiovascular diseases after COVID …

In the wake of the COVID-19 pandemic, millions worldwide are still struggling with persistent
or recurring symptoms known as long COVID. Fatigue is one of the most prevalent …

Current data indicate the existence of post-acute COVID-19 syndrome frequently expressing
as cardiovascular and respiratory health issues. The long-term evolution of these …

Context In 2019, emergence of the novel and communicable severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection took scientific communities by surprise and …